This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy Manufacturing & Commercialization US
Mark Your Calendar for This Year's Event!
September 27-30, 2022Boston Convention and Exhibition Center

Jeffrey Hung
Chief Commercial Officer at Vigene Biosciences, Inc., USA


Dr. Hung has over 20 years of experience in the gene therapy, synthetic biology and drug development.  He joined Vigene in 2016 and orchestrated the acquisition of Omnia Biologics, a GMP manufacturer of viral vectors of 15 years. He has also overseen Vigene’s expansion into GMP manufacturing and new product areas such as biosensors. An experienced entrepreneur, Dr. Hung was instrumental in successfully growing GenScript and SABiosciences, two previous companies, to IPO and acquisition stage, respectively. He also previously held the position of Chief Marketing Officer at ATCC. Jeffrey is the author of multiple patents, publications, and book chapters. He holds a Ph.D. in genetics from Cornell University, an MBA from UC Berkeley, and a B.S. in biology from Peking University.

Agenda Sessions

  • Design, Manufacturing and Analytics of New AAV Reference Materials – A Case Study